Fusion Antibodies picked by "major" pharma firm for antibody project
(Alliance News) - Fusion Antibodies PLC on Wednesday said it has been picked for an antibody services project with a European-based global pharmaceutical company. Read More
Price | 15.00p on 08-10-2025 | at 18:40:06
---|---|
Change | -0.25p -1.64% |
Buy | 15.50p |
Sell | 14.50p |
Last Trade: | Buy 4.00 at 15.175p |
Day's Volume: | 1,790,458 |
Last Close: | 15.00p |
Open: | 15.50p |
ISIN: | GB00BDQZGK16 |
Day's Range | 14.50p - 16.50p |
52wk Range: | 3.85p - 20.50p |
Market Capitalisation: | £17.05m |
VWAP: | 15.19761p |
Shares in Issue: | 113.66m |
Sector: Health Care and Related Services
Listed In: FTSE AIM All-Share,
Fusion Antibodies (FAB) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Buy* | 4 | 15.175p | Ordinary |
16:22:12 - 08-Oct-25 |
Sell* | 15,797 | 14.65p | Ordinary |
16:21:21 - 08-Oct-25 |
Buy* | 23,000 | 15.1499p | Ordinary |
16:18:12 - 08-Oct-25 |
Buy* | 3,966 | 15.175p | Ordinary |
16:18:09 - 08-Oct-25 |
Buy* | 4 | 15.175p | Ordinary |
16:09:50 - 08-Oct-25 |
Buy* | 3,000 | 15.185p | Ordinary |
16:04:18 - 08-Oct-25 |
Sell* | 25,000 | 14.6001p | Ordinary |
15:54:02 - 08-Oct-25 |
Buy* | 193 | 15.185p | Ordinary |
15:39:23 - 08-Oct-25 |
Buy* | 657 | 15.20p | Ordinary |
15:36:41 - 08-Oct-25 |
Buy* | 4 | 15.20p | Ordinary |
15:31:27 - 08-Oct-25 |
Fusion Antibodies (FAB) Regulatory News |
||
Date | Source | Headline |
---|---|---|
8th Oct 2025 7:00 am | RNS | Contract win |
19th Sep 2025 12:58 pm | RNS | Posting of Annual Report & Notice of AGM |
17th Sep 2025 7:00 am | RNS | OptiMAL R&D Update |
8th Sep 2025 7:00 am | RNS-R | Belfast investor presentation |
4th Sep 2025 7:00 am | RNS | Final Results |
28th Aug 2025 7:00 am | RNS | Contract Win |
27th Aug 2025 7:00 am | RNS | Contract wins with existing client |
26th Aug 2025 7:00 am | RNS-R | Investor presentations |
5th Aug 2025 7:00 am | RNS | Grant of U.S. Patent for OptiMAL |
24th Jul 2025 10:56 am | RNS | Issue Notification: US Patent Update |